Dietmar Reichert

Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

Oliver A. Cornely, Johan Maertens, Mark Bresnik et al. · Clinical Infectious Diseases · 2007 · 744 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Treatment of invasive fungal infections in cancer patients—Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Angelika Böhme, Markus Ruhnke, Dieter Buchheidt et al. · Annals of Hematology · 2008 · 121 citations

Medicine, Infectious Diseases, Oncology +17

Effect of Once-Weekly Epoetin Beta on Survival in Patients With Metastatic Breast Cancer Receiving Anthracycline- and/or Taxane-Based Chemotherapy: Results of the Breast Cancer—Anemia and the Value of Erythropoietin (BRAVE) Study

Matti Aapro, Robert Leonard, Agustí Barnadas et al. · Journal of Clinical Oncology · 2008 · 106 citations · Full text

Medicine, Oncology, Pharmacology +16

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Rüdiger Hehlmann, Astghik Voskanyan, Michael Lauseker et al. · Leukemia · 2020 · 92 citations · Full text

Life Sciences, Hematology, Oncology +16

Risk factors for breakthrough invasive fungal infection during secondary prophylaxis

Oliver A. Cornely, Angelika Böhme, Dietmar Reichert et al. · Journal of Antimicrobial Chemotherapy · 2008 · 70 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17